Are Peripapillary Hyperreflective Ovoid Mass-like Structures with an Elevated Optic Disc Still a Diagnosis Dilemma?

被引:0
|
作者
Maalej, Rim [1 ]
Bouassida, Mohamed [1 ]
Picard, Herve [2 ]
Clermont, Catherine Vignal [1 ]
Hage, Rabih [1 ]
机构
[1] Rothschild Fdn Hosp, Dept Neuroophthalmol, 29 Rue Manin, F-75940 Paris 19, France
[2] Rothschild Fdn Hosp, Dept Stat, Paris, France
关键词
D O I
10.1016/j.ophtha.2024.09.007
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Purpose: To identify clinical characteristics that would help make or rule out the diagnosis of idiopathic intracranial hypertension (IIH) in patients referred for papilledema (PE) with peripapillary hyperreflective ovoid mass-like structures (PHOMS). Design: A retrospective cohort study. Participants: All patients referred for PE excluding PE with Fris & eacute;n grade >= 3, optic neuritis, ischemic optic neuropathy, and compressive optic neuropathy. Patients were divided into 2 groups: group 1 = isolated PHOMS; group 2 = PHOMS associated with IIH. Methods: We analyzed the location of PHOMS based on OCT-enhanced depth imaging (EDI) and calculated their volume. Main outcome measures: Peripapillary retinal nerve fiber layer (pRNFL), ganglion cell complex, and volume of PHOMS. Results: A total of 154 patients (308 eyes) were included. Patients' mean age was 29 years, with a female predominance (78%). Peripapillary hyperreflective ovoid mass-like structures were associated with these etiologies: IIH (38.3%), isolated (35.7%), posterior uveitis (11%), optic disc drusen (ODD) (10%), and tilted optic disc (5%). Magnetic resonance imaging (MRI) was performed in 83.1% of cases. More than half of the MRI scans were interpreted as consistent with IIH. However, only 39.7% of these patients had confirmed IIH with 44.5% sensitivity and 55.5% specificity. Peripapillary hyperreflective ovoid mass-like structures were overrepresented in the nasal region (95.5%).The location of PHOMS in the superior or inferior quadrant was significantly associated with IIH or ODD, whereas their presence in the temporal or nasal sector was strongly associated with isolated lesions. The mean and median volume of PHOMS were 1.66 mu m(3) and 1.50 mu m(3), respectively. There was a significant difference in PHOMS volume, with a higher volume in patients with IIH (P = 0.0037). Follow-up of these patients at 3 and 6 months demonstrated no significant changes in visual function, as per visual field mean deviation, visual acuity measurements, and ganglion cell layer. Mean pRNFL showed a decrease of -4.225 mu m at 3 months and -6.489 mu m at 6 months when compared with the initial measurement independent of the etiology. Conclusions: Isolated PHOMS should be considered as a distinct entity. In asymptomatic patients, PHOMS should be carefully studied. Nasal or temporal location, small volume, and stable aspect over the course of weeks or months are suggestive of this entity. This strategy would considerably reduce the impact on patients' anxiety and morbidity.
引用
收藏
页码:309 / 316
页数:8
相关论文
共 50 条
  • [21] Prevalence of peripapillary hyperreflective ovoid mass-like structures (PHOMS) in suspected papilloedema in children
    Luke Pratt
    Shahzaib Rehan
    Jack West
    Patrick Watts
    Eye, 2023, 37 : 3209 - 3212
  • [22] Peripapillary Hyperreflective Ovoid Mass-like Structures (PHOMS) in Patients with Acute Leber's Hereditary Optic Neuropathy
    Cascavilla, Maria
    Borrelli, Enrico
    Battista, Marco
    Lari, Giorgio
    Albertini, Stefano
    De Negri, Anna
    Coutinho, Catarina
    Galzignato, Alice
    La Morgia, Chiara
    Ricciotti, Guido
    Carbonelli, Michele
    Carelli, Valerio
    Bandello, Francesco
    Barboni, Piero
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2023, 64 (08)
  • [23] Peripapillary hyperreflective ovoid mass-like structures and the retinal nerve fiber layer thinning
    Rabinovich, Mark
    Seray, Samia
    Amoroso, Francesca
    Madar, Charles
    Souied, Eric H.
    EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2024, 34 (02) : NP126 - NP130
  • [24] Peripapillary hyperreflective ovoid mass-like structures (PHOMS) in patients with acute Leber’s hereditary optic neuropathy
    Enrico Borrelli
    Maria Lucia Cascavilla
    Giorgio Lari
    Anna Maria De Negri
    Marco Battista
    Alice Galzignato
    Catarina Coutinho
    Alessandro Berni
    Costanza Barresi
    Guido Ricciotti
    Francesco Bandello
    Piero Barboni
    Graefe's Archive for Clinical and Experimental Ophthalmology, 2024, 262 : 261 - 265
  • [25] Prevalence of peripapillary hyperreflective ovoid mass-like structures (PHOMS) in suspected papilloedema in children
    Pratt, Luke
    Rehan, Shahzaib
    West, Jack
    Watts, Patrick
    EYE, 2023, 37 (15) : 3209 - 3212
  • [26] Is the presence of peripapillary hyperreflective ovoid mass-like structures (PHOMS) in children related to the optic disc area, scleral canal diameter and refractive status?
    Pratt, Luke
    Rehan, Shahzaib
    West, Jack
    Watts, Patrick
    EYE, 2025, 39 (02) : 296 - 299
  • [27] Features of Peripapillary Hyperreflective Ovoid Mass-Like Structures in Nonarteritic Anterior Ischemic Optic Neuropathy Patients and Normal Controls
    Wang, Wenyu
    Liu, Juejun
    Xiao, Di
    Yi, Zuohuizi
    Chen, Changzheng
    TRANSLATIONAL VISION SCIENCE & TECHNOLOGY, 2024, 13 (01):
  • [28] Peripapillary hyperreflective ovoid mass-like structures—a novel entity as frequent cause of pseudopapilloedema in children
    Daphna Mezad-Koursh
    Ainat Klein
    Amir Rosenblatt
    Sharon Teper Roth
    Meira Neudorfer
    Anat Loewenstein
    Matias Iglicki
    Dinah Zur
    Eye, 2021, 35 : 1228 - 1234
  • [29] Peripapillary hyperreflective ovoid mass-like structures (PHOMS): OCTA may reveal new findings
    Borrelli, Enrico
    Barboni, Piero
    Battista, Marco
    Sacconi, Riccardo
    Querques, Lea
    Cascavilla, Maria Lucia
    Bandello, Francesco
    Querques, Giuseppe
    EYE, 2021, 35 (02) : 528 - 531
  • [30] Peripapillary hyperreflective ovoid mass-like structures in multiple sclerosis are associated with disease progression.
    Petzold, A.
    Coric, D.
    Uitdehaag, B. M. J.
    Balk, L.
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 : 115 - 115